We use privacy-friendly, cookieless analytics (Plausible) plus one first-party cookie for anonymous visit counting — no advertising and no cross-site tracking. See our Cookie Policy and Privacy Policy.

Data & benchmarks

Federal IDR win-rate benchmarks

How often providers win out-of-network disputes under the No Surprises Act — overall and by specialty. These figures are drawn from the public CMS Federal IDR Public Use Files for 2025 (about 2.18 million determinations), the same data Sydra is built on.

~85%

provider win rate, all specialties (2025)

2.18M

federal IDR determinations in 2025

$115 → $15

IDR filing fee, per party (June 2026 rule)

Provider win rate by specialty

SpecialtyWin rateNotes
All specialties (weighted)~85%Providers prevail in the large majority of determinations.
Orthopedic / spine / neurosurgery~87%Highest — surgical claims rarely lose.
Hospitals & facilities~86%Facility and observation claims.
Emergency medicine~85%The archetypal No Surprises Act claim.
Pathology & clinical labs~84%Hospital-based reads the patient never chose.
Anesthesia~82%Lowest of the major specialties — base-plus-time billing.

Weighted by decided line items, CMS Federal IDR Public Use Files, calendar year 2025. Figures are rounded; individual practices vary widely — many self-filing groups win far below these benchmarks.

The 2026–2027 changes

  • Lower fee. The IDR administrative fee dropped from $115 to $15 per party, per dispute (initiated on or after June 11, 2026) — smaller claims now pencil out.
  • Bigger batches. From November 1, 2026, up to 50 related services can be batched into one dispute.
  • Standardized payer codes. For items and services on or after January 1, 2027, payers must attach standardized CARC/RARC codes and their IDR registration number to every payment or denial.

Where does your practice stand?

If you're winning well below ~85%, the gap is almost always process — eligibility, deadlines, evidence, and offer justification — not the merits. Sydra shows you your win and default rates by payer and code, and closes the gap for a flat fee.

JA

Medically & clinically reviewed by Dr. John M. Abrahams, MD

Board-certified neurosurgeon and founder of Sydra · Last reviewed September 2026 · About the author

Figures reflect the published federal record across all disputes, not a prediction about any individual claim. This is general information, not legal or financial advice.